Oral etoposide is active against platinum-resistant epithelial ovarian cancer.
Year: 1994
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: P J Hoskins, K D Swenerton
Institution: BC Cancer Agency
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1939163116
